Zinc-naproxen complex: Synthesis, physicochemical and biological evaluation

International Journal of Pharmaceutics

Volumn 260, Issue 2, 2003, Pages 217-227

  Sharma, Jyoti ^a   Singla, Anil K ^a   Dhawan, S ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Anti inflammatory activity; Naproxen; Ulcerogenic activity; Zinc naproxen complex

Indexed keywords

NAPROXEN; ZINC SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; ULTRAVIOLET SPECTROSCOPY;

EID: 0038121687     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00251-5     Document Type: Article

References (37)

1. Aabakken L., Ugstad M., Gamst O.N., Winther R., Osnes M. Naproxen-associated gastroduodenal toxicity: enteric coated granules versus plain tablets. Eur. J. Rheumatol. Inflamm. 12:1992;43-48.
2. Albert, A., 1985. Selective Toxicity, 7th ed., Chapman and Hall, New York, pp. 464-466.
3. Al-Shammary, F.J., Mian, N.A.A., Mian, M.S., 1992. Naproxen, In: Florey, Klaus (Eds.), Analytical Profile of Drug Substances, vol. 21. Academic Press Inc., New York, pp. 345-373.
4. Calis S., Bozdag S., Kas H.S., Tuncay M., Hincal A.A. Influence of irradiation sterilization on poly(lactide-co-glycolide) microspheres containing anti-inflammatory drugs. Farmacologia. 57:2002;55-62.
5. Chakrabarti S., Southard M.Z. Control of poorly soluble drug dissolution in condition simulating the gastrointestinal tract flow. 2. Cocompression of drugs with buffers. J. Pharm. Sci. 86:1997;465-469.
6. Chiu P.J., Vemulapalli S., Barnett A. Lysosomal enzyme release and ethanol-induced gastric lesions in rats. J. Pharm. Pharmacol. 35:1983;121-123.
7. 2 and histamine levels in rat glandular mucosa. Digestion. 32:1985;285-295.
8. Chvapil M., Ryan J.N., Zukoski C.F. The effect of zinc and other metals on the stability of lysosomes. Proc. Soc. Exp. Biol. Med. 140:1972;642-646.
9. Clemmenson O.J., Siggaard-Andersen J., Worm A.M., Stahl D., Frost F., Bloch I. Psoriatic arthiritis treated with oral zinc sulphate. Br. J. Dermatol. 103:1980;411-415.
10. Dreno B., Boiteau H.L., Litoux P. Anti-inflammatory action of zinc related to cutaneous pathology. Met. Ions Biol. Sys. Proc. Int. Symp. I:1990;14-17.
11. Espinar F.J.O., Igea S.A., Mendez J.B., Jato J.L.V. Reduction in ulcerogenicity of naproxen by complexation with β-cyclodextrin. Int. J. Pharm. 70:1991;35-41.
12. Evans G.W., Jhonson P.F. Characterization and quantification of a zinc-binding ligand in human milk. Pediatr. Res. 14:1980;876-880.
13. Frechilla D., Lasheras B., Ucelay M., Parrondo E., Craciunescu G., Cenarruzabeitia E. Anti-inflammatory activity of some copper complexes. Arzneim. Forsch. 40:1990;914-917.
14. Fraser P.M., Doll R., Langman M.J.S., Misiewicz J.J., Shawdon H.H. Clinical trial of a new carbenoxolone analogue (BX24), zinc sulphate and vitamin A in the treatment of gastric ulcer. Gut. 13:1972;459-463.
15. Frommer D.J. The healing of gastric ulcers by zinc sulphate. Med. J. Aust. 2:1975;793-796.
16. Guth P.H., Hall P. Microcirculatory and most cell changes in restraint-induced ulcer. Gastroenterology. 50:1996;562-570.
17. Higgs G.A., Flower R.J., Vane J.R. A new approach to anti-inflammatory drugs. Biochem. Pharmacol. 28:1979;1959-1961.
18. Huskisson E.C., Bernstein R.M., Coppock J.S., Davies P.G., Doyle D.V., Platt P.R., Scott D.L., Witherington R.H., Wojtulewski J.A. Enteric coated naproxen: a double blind trial comparing the tolerance of enteric coated and standard formulations. Eur. J. Rheumatol. Inflamm. 12:1992;27-30.
19. Karl L., Chvapil M., Zukoski C.F. Effect of zinc on the viability and phagocytic capacity of peritoneal macrophages. Proc. Soc. Exp. Bio. Med. 142:1973;1123-1127.
20. Muscara M.N., McKnight W., Asfaha S., Wallace J.L. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor. Br. J. Pharmacol. 129:2000;681-686.
21. Nasirideen S., Kas H.S., Oner F. Naproxen incorporated lipid emulsions. I. Formulation and stability studies. J. Clin. Pharmacol. Therap. 23:1998;57-65.
22. 1. Recueil. 85:1966;405-410.
23. Otterness I.G., Gans D.J. Nonsteroidal anti-inflammatory drugs: an analysis of the relationship between clinical doses, including species scaling. J. Pharm. Sci. 77:1988;790-795.
24. Reynolds, J.E.F. (Eds), 1993. Martindale, The Extra Pharmacopoeia, 30th ed. The Pharmaceutical Press, London, pp. 3-7, 17-21, 1064.
25. Schoen R.T., Vender R.J. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. Am. J. Med. 86:1989;449-458.
26. Shandhag V.R., Crider A.M., Gokhale R., Harpalani A. Ester and amide prodrugs of ibuprofen and naproxen: synthesis, anti-inflammatory activity and gastrointestinal toxicity. J. Pharm. Sci. 81:1992;149-154.
27. Simkin P.A. Oral zinc sulphate in rheumatoid arthritis. Lancet. ii:1976;539-542.
28. Singla A.K., Nagra L. Release enhancement and reduction in ulcerogenecity of naproxen by polyvinylpyrrolidine. Ind. J. Pharm. Sci. 62:2000;126-128.
29. Singla A.K., Wadhwa H. Zinc aspirin complex: synthesis, physicochemical and biological evaluation. Int. J. Pharm. 108:1994;173-185.
30. Singla A.K., Wadhwa H. Zinc indomethacin complex: synthesis, physicochemical and biological evaluation. Int. J. Pharm. 120:1995;145-155.
31. Todd P.A., Clissold S.P. Naproxen: a reappraisal of its pharmacological and atherapeutic use in rheumatic disease and pain states. Drugs. 40:1990;91-137.
32. Vinegar R., Schreiber W., Hugo R. Biphasic development of carrageenan oedema in rats. J. Pharmcol. Exp. Ther. 166:1969;96-103.
33. Willard, H.H., Merritt, L.L., Jr., Dean, J.A., Settle, Jr., 1986. Instrumental Methods of Analysis, 6th ed., EBS Publishers, Delhi by arrangement with Wadsworth, U.S.A., pp. 611-613.
34. Williams D.A., Walz D.T., Foye W.O. Synthesis and biological evaluation of tetrakis(acetylsalicylato)-μ-di-copper (II). J. Pharm. Sci. 65:1976;126-128.
35. Winter C.A., Risley E.A., Nuss G.W. Carrageenin-induced oedema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med. 111:1962;544-547.
36. Wong S.H., Cho C.H., Ogle C.W. Protection by zinc sulphate against ethanol-induced ulceration: preservation of the gastric mucosal barrier. Pharmacology. 33:1986;94-102.
37. Yamamoto K., Takahashi M. Inhibition of the terminal stage of complement-mediated lysis (reactive lysis) by zinc and copper ions. Int. Arch. Allergy Appl. Immun. 48:1975;653-663.